Marton Tompa
Overview
Explore the profile of Marton Tompa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
58
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sonkodi B, Kovats T, Galik B, Tompa M, Urban P, Nagy Z, et al.
Int J Mol Sci
. 2024 Nov;
25(21).
PMID: 39519393
Competitive athletes are often exposed to extreme physiological loading, resulting in over excessive mechanotransduction during their acute intensive training sessions and competitions. Individual differences in their genetics often affect how...
2.
Tompa M, Galik B, Urban P, Kajtar B, Kraboth Z, Gyenesei A, et al.
Int J Mol Sci
. 2024 Jul;
25(14).
PMID: 39062807
OMICS methods brought significant advancements to the understanding of tumor cell biology, which transformed the treatment and prognosis of several cancers. Clinical practice and outcomes, however, changed significantly less in...
3.
Sinko G, Tompa M, Kiss Z, Kalman B
Ideggyogy Sz
. 2024 Jun;
77(5-6):207-211.
PMID: 38829246
Background -Leukodystrophies, a heterogeneous group of brain and spinal cord disorders, often pose challenges in establishingmolecular etiology. Vanishing White Matter Disease (VWMD) is a rare subtype of leukodystrophies presenting with...
4.
Kraboth Z, Tompa M, Urban P, Galik B, Kajtar B, Gyenesei A, et al.
Ideggyogy Sz
. 2024 Feb;
77(1-2):27-37.
PMID: 38321856
Background And Purpose: Glioblastoma (GBM), a highly aggressive form of brain tumors, has been extensively studied using OMICS methods, and the most characteristic molecular determinants have been incorporated into the...
5.
Tompa M, Kraboth Z, Galik B, Kajtar B, Gyenesei A, Kalman B
Biomedicines
. 2022 Sep;
10(9).
PMID: 36140275
Background: Immune evasion in glioblastoma (GBM) shields cancer cells from cytotoxic immune response. Methods: We investigated CpG methylation in promoters, genes, and pathways in 22 pairs of formalin-fixed paraffin-embedded sequential...
6.
Nagy A, Tompa M, Kraboth Z, Garzuly F, Maraczi A, Kalman B
Ideggyogy Sz
. 2021 Oct;
74(9-10):349-355.
PMID: 34657400
Background And Purpose: Aberrant activation of the Wnt pathway contributes to differentiation and maintenance of cancer stem cells underlying gliomagenesis. The aim of our research was to determine as to...
7.
Tompa M, Kajtar B, Galik B, Gyenesei A, Kalman B
Pathol Res Pract
. 2021 Apr;
222:153429.
PMID: 33857857
Background: Wnt signaling plays important roles in tumorigenesis, invasiveness and therapeutic resistance of glioblastoma (GBM). Methods: We simultaneously investigated six Wnt pathway markers (Wnt5a, Fzd-2, beta-catenin, Wnt3a, Wnt7b, Fzd-10) at...
8.
Kraboth Z, Galik B, Tompa M, Kajtar B, Urban P, Gyenesei A, et al.
J Cancer Res Clin Oncol
. 2020 Aug;
146(11):2885-2896.
PMID: 32779022
Purpose: Glioblastoma is the most aggressive form of brain tumors. A better understanding of the molecular mechanisms leading to its evolution is essential for the development of treatments more effective...
9.
Tompa M, Nagy A, Komoly S, Kalman B
Brain Res
. 2019 May;
1718:114-125.
PMID: 31075260
Glioblastoma (GBM) is a highly heterogeneous and aggressive brain tumor. Comprehensive genomic and transcriptomic analyses revealed that GBM segregates into three subgroups with characteristic signaling pathways. The Wnt pathway recently...
10.
Kalovits F, Takats L, Somogyi K, Garzuly F, Tompa M, Kalman B
Ideggyogy Sz
. 2019 Apr;
72(3-4):141-144.
PMID: 30957470
Secretory meningioma is a rare form of meningiomas which differentiates from the meningothelial subtype. It is characterized by significant peritumor edema and distinct immunohistochemical and molecular genetic profiles. We present...